Search - tctmd.com

Displaying 21 - 33 of 33

Sort: Relevancy | Date

Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’

News Conference News ISET 2018

Noninvasive Testing of CLI: Many Ways to Draw Up a ‘Roadmap’

February 05, 2018

EVAR Outcomes Equivalent Between Men and Women, Registries Show

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

September 14, 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

News Conference News ISET 2017

Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs?

February 17, 2017

News Conference News TCT 2016

Transcaval TAVR Presents New Option for Patients With Complex Anatomy

Yael L. Maxwell

October 29, 2016

News Conference News VIVA 2016

Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions

September 22, 2016

News Conference News VIVA 2016

IVUS Improves Management of Iliofemoral Venous Stenting

September 20, 2016

News Conference News AHA 2013

Endovascular Revascularization Benefits PAD Patients When Added to Exercise Therapy

Yael L. Maxwell

November 18, 2013

News Conference News ESC 2013

Novel Anticoagulant Edoxaban Surpasses Warfarin Across Spectrum of VTE Patients

September 02, 2013

News Conference News EuroPCR 2013

Treatment of Most Endovascular Lesions Feasible with 4-Fr Devices

May 22, 2013

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

November 06, 2012

News Conference News TCT 2012

Endurant Stent Graft for AAA Safe, Effective at 2 Years

October 29, 2012

News Conference News SCAI 2012

MOBILITY Supports Iliac Stenting in Extensive PAD Cases

May 11, 2012

News Conference News

ACTIVE Results Demonstrate Safety and Efficacy of Cobalt Chromium Stent in Treatment of PVD

November 06, 2011

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.